Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
4(80.0%)
Phase 2
1(20.0%)
5Total
Phase 1(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05408091Phase 1Completed

Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers

Role: lead

NCT07644195Phase 1Not Yet Recruiting

Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers

Role: lead

NCT06621251Phase 2Active Not Recruiting

Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection

Role: lead

NCT04763759Phase 1Completed

Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections

Role: lead

NCT05355207Phase 1Unknown

Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis

Role: lead

All 5 trials loaded